Ferdinand Keith C, Reddy Tina K
Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112, USA.
Am J Prev Cardiol. 2021 Dec;8:100283. doi: 10.1016/j.ajpc.2021.100283. Epub 2021 Oct 16.
In 2020, COVID-19 was the third leading cause of death in the US, with increased hospitalizations and mortality linked to factors such as obesity, hypertension, diabetes, higher social vulnerability, and lower socioeconomic status. These multiple factors contribute to inequities in COVID-19 outcomes, including among older persons, members of racial/ethnic populations, and persons experiencing homelessness. Perhaps the best pathway to overcome the distressing high degree of death and disability due to COVID-19 has shown to be immunization with widespread acceptance, uptake, and vaccine access. Especially in racial/ethnic communities, it is important to utilize trusted leaders to overcome common vaccine misconceptions and barriers. This commentary summarizes the keynote lecture given to the Cardiometabolic Health Congress (CMHC) addressing the intersection of social injustice, cardiovascular and cardiometabolic disparities, and increased COVID-19 morbidity and mortality in racial/ethnic populations in the US.
2020年，新冠病毒病是美国第三大死亡原因，住院率和死亡率上升与肥胖、高血压、糖尿病、社会脆弱性较高以及社会经济地位较低等因素有关。这些多重因素导致了新冠病毒病结局的不平等，包括老年人、种族/族裔群体成员以及无家可归者。或许，克服新冠病毒病造成的令人痛心的高死亡率和高致残率的最佳途径已证明是广泛接受、接种和获得疫苗的免疫接种。特别是在种族/族裔社区，利用受信任的领导人来克服常见的疫苗误解和障碍非常重要。本评论总结了在心脏代谢健康大会（CMHC）上发表的主题演讲，该演讲探讨了美国社会不公正、心血管和心脏代谢差异以及种族/族裔人群中新冠病毒病发病率和死亡率增加之间的交叉问题。
